More Business Wire
View Older Stories View Newer Stories-
KalVista Pharmaceuticals Receives Positive CHMP Opinion for Sebetralstat for the Treatment of Hereditary Angioedema Attacks
-
Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7
-
Omeros Corporation Announces Pricing of $22 Million Registered Direct Offering
-
InvoiceCloud Recognized as Technology Top Workplace for the Fourth Consecutive Year
-
GrabAGun Applauds Ruling Upholding Second Amendment
-
Venova Technologies Awarded $2.23M SBIR Phase II Grant From NIH For Novel Contraceptive Device
-
Strategy Announces Pricing of Initial Public Offering of STRC Stock
-
The Vascular Care Group Welcomes Dr. Scott James as Newest Physician Partner
-
American College of Diabetology Announces Formal Taxonomy Classification for Diabetology
-
ARKEMA: Statement about the number of shares and voting rights in compliance with the article L.233-8 II of the French commercial code and the article 223-16 of the Financial Markets Authority (AMF-A
-
HCA Healthcare Reports Second Quarter 2025 Results
-
Customers Bancorp Announces Executive Leadership Transition
-
Gold Reserve Provides Update on Objections to the Special Master’s Final Recommendation in the CITGO Sale Process
-
AMC Entertainment Holdings, Inc. Announces Successful Closing of Comprehensive Refinancing Transactions that Strengthen the Balance Sheet and Position the Company to Prosper from Robust Box Office Rec
-
Canopy Growth to Report First Quarter Fiscal 2026 Financial Results on August 8, 2025
-
TRYNGOLZA® (olezarsen) recommended for approval in the EU by CHMP for familial chylomicronemia syndrome (FCS)
-
Moog Inc. Announces Cash Dividend
-
FHLBank Chicago Celebrates Grand Opening of the Harry and Jeanette Weinberg Residences at Woodale Crossing
-
Stellar Bancorp, Inc. Reports Second Quarter 2025 Results
-
Virtus Investment Partners Announces Financial Results for Second Quarter 2025
-
Phillips 66 Reports Second-Quarter Results
-
Moog Inc. Reports Third Quarter 2025 Results With Both Record Sales and Earnings Per Share
-
ACCO Brands Corporation Declares Quarterly Dividend
-
Cristian Massacesi, M.D., Joins Bristol Myers Squibb as Executive Vice President, Chief Medical Officer and Head of Development
-
Sensient Technologies Corporation Reports Results for the Quarter Ended June 30, 2025
-
Kontoor Brands Declares Quarterly Dividend
-
Gorman-Rupp Company Declares Cash Dividend
-
Gorman-Rupp Reports Second Quarter 2025 Financial Results
-
AST SpaceMobile Announces Pricing of Private Offering of $500.0 Million of Convertible Senior Notes Due 2032 (Effective Conversion Price of $120.12 per Share with Capped Call)
-
AST SpaceMobile Prices Repurchase of Convertible Senior Notes to be Funded By Concurrent Registered Direct Offering of Class A Common Stock
-
Kenvue to Announce Second Quarter 2025 Results on August 7, 2025
-
Booz Allen Hamilton Announces First Quarter Fiscal Year 2026 Results
-
GrafTech Reports Second Quarter 2025 Results
-
Central Pacific Financial Reports Second Quarter 2025 Earnings of $18.3 Million
-
ALLETE Board of Directors Declares Dividend on Common Stock
-
Seoul Takes Over Paris – Seoul Design Foundation Sets the Global Stage at Maison&Objet Paris
-
ImmunityBio, Inc. Announces Execution of $80 Million Equity Financing from Multiple Institutional Investors
-
Carter’s, Inc. Reports Second Quarter Fiscal 2025 Results
-
Endoscopic AI: AI Medical Service Inc. Has Obtained Regulatory Approval from Thailand’s FDA for Its Gastric AI-based Endoscopic Diagnosis Support System
-
ImmunityBio Reports 60% Increase in Revenue in Q2 2025, with Year-to-Date Sales of $43 Million and 246% Unit Growth Since J-Code with Regulatory Updates
-
Dorian LPG Ltd. Announces First Quarter 2026 Earnings and Conference Call Date
-
American Strategic Investment Co. Announces Release Date for Second Quarter Results
-
Industry-focused Specialist IT/ITES Firm eClerx Delivers Strong Q1 FY26 Performance
-
European Firms Embrace Google Cloud Ecosystem
-
Gilead Receives Positive CHMP Opinions Under Accelerated Review From European Medicines Agency for Twice-Yearly Lenacapavir for HIV Prevention
-
Samsung Launches Galaxy Z Fold7, Galaxy Z Flip7 and Galaxy Watch8 Series Globally Starting Today
-
Luigi de Vecchi to Join Evercore’s European Advisory Practice as Firm Continues to Build in Europe
-
ADOCIA and Tonghua Dongbao Announce Positive Topline Results of Phase 3 Clinical Trial on Ultra-Rapid Insulin BioChaperone® Lispro (THDB0206 injection) in People with T2D
-
Oasis Continues to Call for the Dismissal of Kusuri No Aoki’s President and Vice President (Stock Code: 3549 JT)
-
Temenos Recognized by CNBC as One of the World’s Top Fintech Companies
